<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04755283</url>
  </required_header>
  <id_info>
    <org_study_id>ANT-006</org_study_id>
    <secondary_id>2020-004507-13</secondary_id>
    <nct_id>NCT04755283</nct_id>
  </id_info>
  <brief_title>Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation</brief_title>
  <acronym>AZALEA-TIMI 71</acronym>
  <official_title>A Multicenter, RandomiZed, Active-ControLled Study to Evaluate the Safety and Tolerability of Two Blinded Doses of Abelacimab (MAA868) Compared With Open-Label Rivaroxaban in Patients With Atrial Fibrillation (AZALEA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anthos Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The TIMI Study Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Covance</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Anthos Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the ANT-006 study is to evaluate the bleeding profile of abelacimab relative&#xD;
      to rivaroxaban in patients with atrial fibrillation (AF) at moderate-to-high risk of stroke.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2, 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is an event-driven, randomized, active-controlled, blinded endpoint, parallel-group study to evaluate the effect of two blinded doses of abelacimab relative to open-label rivaroxaban on the rate of major or clinically relevant non-major (CRNM) bleeding events in patients with atrial fibrillation (AF) who are at moderate-to-high risk of stroke.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>All care providers are blinded with the exception of the pharmacist and study team member assigned to administer the subcutaneous injection of abelacimab.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate effect of abelacimab relative to rivaroxaban on the rate of major or clinically relevant non-major (CRNM) bleeding events</measure>
    <time_frame>From randomization through study completion, an average of 17 months</time_frame>
    <description>Time to first event of composite of International Society on Thrombosis and Haemostasis (ISTH)-defined major bleeding or CRNM bleeding events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate effect of abelacimab relative to rivaroxaban on the rate of major bleeding events</measure>
    <time_frame>From randomization through study completion, an average of 17 months</time_frame>
    <description>Time to first event ISTH-defined major bleeding events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the effect of abelacimab relative to rivaroxaban on the rate of major or minor bleeding events</measure>
    <time_frame>From randomization through study completion, an average of 17 months</time_frame>
    <description>Time to first event ISTH-defined major or minor bleeding events</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Atrial Fibrillation (AF)</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Abelacimab (MAA868)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment group 1: Abelacimab middle dose subcutaneous (s.c.) monthly&#xD;
Treatment group 2: Abelacimab high dose subcutaneous (s.c.) monthly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rivaroxaban</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment group 3: Rivaroxaban 20 mg by mouth; orally (p.o.) once per day with the evening meal&#xD;
Patients with a Creatinine Clearance (CrCl) ≤50 ml/min by the Cockcroft-Gault equation will have a dose adaptation to rivaroxaban 15 mg p.o. daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Abelacimab</intervention_name>
    <description>Abelacimab provided as liquid in vial (150 mg/mL)</description>
    <arm_group_label>Abelacimab (MAA868)</arm_group_label>
    <other_name>MAA868</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rivaroxaban</intervention_name>
    <description>Rivaroxaban 15 mg and 20 mg provided as commercially available film-coated tablets</description>
    <arm_group_label>Rivaroxaban</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female patients ≥ 55 years old&#xD;
&#xD;
          -  Patients with a history of atrial fibrillation (AF) or atrial flutter with planned&#xD;
             indefinite anticoagulation&#xD;
&#xD;
          -  Patients with a CHA2DS2-VASc of ≥4 OR a CHA2DS2-VASc of ≥3 with at least 1 of the&#xD;
             following:&#xD;
&#xD;
               1. Planned concomitant use of antiplatelet medication use (i.e., aspirin and/or&#xD;
                  P2Y12 inhibitor) for the duration of the trial&#xD;
&#xD;
               2. Creatinine Clearance (CrCl) ≤50 ml/min by the Cockcroft-Gault equation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of hypersensitivity to any of the study drugs (including rivaroxaban) or its&#xD;
             excipients, to drugs of similar chemical classes, or any contraindication listed in&#xD;
             the label for rivaroxaban&#xD;
&#xD;
          -  Patients with an intracranial or intraocular bleed within the 3 months prior to&#xD;
             screening&#xD;
&#xD;
          -  Clinically significant mitral stenosis (valve area &lt;1.5 cm2)&#xD;
&#xD;
          -  Mechanical heart valve&#xD;
&#xD;
          -  Known presence of an atrial myxoma or left ventricular thrombus&#xD;
&#xD;
          -  History of left atrial appendage closure or removal&#xD;
&#xD;
          -  Active endocarditis&#xD;
&#xD;
        Other protocol defined Inclusion/Exclusion criteria may apply&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Janeen Salter</last_name>
    <phone>1-617-430-6957</phone>
    <email>info@anthostherapeutics.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32114-2321</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Largo</city>
        <state>Florida</state>
        <zip>33777</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Safety Harbor</city>
        <state>Florida</state>
        <zip>34695</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Saint Augustine</city>
        <state>Florida</state>
        <zip>32086</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Johns Creek</city>
        <state>Georgia</state>
        <zip>30024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21229-5222</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Framingham</city>
        <state>Massachusetts</state>
        <zip>01701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <zip>01830</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Dover</city>
        <state>New Hampshire</state>
        <zip>03820</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Sewell</city>
        <state>New Jersey</state>
        <zip>08080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Southampton</city>
        <state>New York</state>
        <zip>11968</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Lenoir</city>
        <state>North Carolina</state>
        <zip>28645</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Kingwood</city>
        <state>Texas</state>
        <zip>77339</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Odessa</city>
        <state>Texas</state>
        <zip>79761-5133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Tomball</city>
        <state>Texas</state>
        <zip>77375</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Manassas</city>
        <state>Virginia</state>
        <zip>20109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>New Westminster</city>
        <state>British Columbia</state>
        <zip>V3L 3W5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 7R1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 5G8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <zip>L1J2K1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <zip>P3B 4H5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Greenfield Park</city>
        <state>Quebec</state>
        <zip>J4V 2G8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H1T 3Y7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Mariánské Lázně</city>
        <state>KA</state>
        <zip>353 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Trutnov</city>
        <state>KR</state>
        <zip>541 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Liberec</city>
        <state>LB</state>
        <zip>460 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Liberec</city>
        <state>LI</state>
        <zip>460 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Česká Lípa</city>
        <state>LI</state>
        <zip>470 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Pardubice</city>
        <state>PA</state>
        <zip>530 02</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Praha</city>
        <state>PR</state>
        <zip>10100</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Praha</city>
        <state>PR</state>
        <zip>110 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Praha</city>
        <state>PR</state>
        <zip>158 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Benešov</city>
        <state>Středočeský Kraj</state>
        <zip>256 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Brandýs Nad Labem</city>
        <state>Středočeský Kraj</state>
        <zip>250 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Poděbrady</city>
        <state>Středočeský Kraj</state>
        <zip>29001</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Příbram</city>
        <state>Středočeský Kraj</state>
        <zip>261 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Slaný</city>
        <state>Středočeský Kraj</state>
        <zip>274 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Kroměříž</city>
        <state>ZL</state>
        <zip>767 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Holešov</city>
        <state>Zlín</state>
        <zip>769 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Orosháza</city>
        <state>BE</state>
        <zip>5900</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Baja</city>
        <state>BK</state>
        <zip>6500</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Budapest</city>
        <state>BP</state>
        <zip>1036</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Budapest</city>
        <state>BP</state>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Budapest</city>
        <state>BU</state>
        <zip>1033</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Budapest</city>
        <state>BU</state>
        <zip>1085</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Budapest</city>
        <state>BU</state>
        <zip>1134</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Budapest</city>
        <state>BU</state>
        <zip>1145</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Miskolc</city>
        <state>BZ</state>
        <zip>3526</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Székesfehérvár</city>
        <state>FE</state>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Debrecen</city>
        <state>HB</state>
        <zip>4025</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Gyöngyös</city>
        <state>HE</state>
        <zip>3200</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Szeged</city>
        <state>SD</state>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Kaposvár</city>
        <state>SO</state>
        <zip>7400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site (4002)</name>
      <address>
        <city>Nyíregyháza</city>
        <state>SZ</state>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site (4003)</name>
      <address>
        <city>Nyíregyháza</city>
        <state>SZ</state>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Balatonfüred</city>
        <state>VE</state>
        <zip>8230</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Balatonfüred</city>
        <state>VM</state>
        <zip>8230</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Seogu</city>
        <state>Busan</state>
        <zip>49201</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi</state>
        <zip>13496</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Daegu</city>
        <zip>41931</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Daegu</city>
        <zip>705-718</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Gwangju</city>
        <zip>61469</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Seoul</city>
        <zip>158-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Seoul</city>
        <zip>2447</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Seoul</city>
        <zip>3080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Seoul</city>
        <zip>3722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Seoul</city>
        <zip>7061</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Łódź</city>
        <state>AL</state>
        <zip>90-442</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Wrocław</city>
        <state>DS</state>
        <zip>51-124</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Wrocław</city>
        <state>DS</state>
        <zip>51-162</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Żarów</city>
        <state>DS</state>
        <zip>58-130</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Gdynia</city>
        <state>GDY</state>
        <zip>81-423</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Zamość</city>
        <state>LB</state>
        <zip>22-400</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Łódź</city>
        <state>LD</state>
        <zip>91-002</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Łódź</city>
        <state>LD</state>
        <zip>92-213</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Lublin</city>
        <state>LU</state>
        <zip>20-001</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Chrzanów</city>
        <state>MA</state>
        <zip>32-500</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Kraków</city>
        <state>MA</state>
        <zip>30-688</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Kraków</city>
        <state>MA</state>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Płock</city>
        <state>MZ</state>
        <zip>09-402</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Warsaw</city>
        <state>MZ</state>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Warszawa</city>
        <state>MZ</state>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Przemyśl</city>
        <state>PK</state>
        <zip>05-825</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Przemyśl</city>
        <state>PK</state>
        <zip>37-700</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Gdynia</city>
        <state>PM</state>
        <zip>81-157</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Bielsko-Biala</city>
        <state>SL</state>
        <zip>43-316</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Dąbrowa Górnicza</city>
        <state>SL</state>
        <zip>41-300</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Ruda Śląska</city>
        <state>SL</state>
        <zip>41-710</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Tychy</city>
        <state>SL</state>
        <zip>43-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Elbląg</city>
        <state>WN</state>
        <zip>82-300</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Changhua</city>
        <state>CHA</state>
        <zip>500</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Taipei</city>
        <state>HSZ</state>
        <zip>30071</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Hualien City</city>
        <state>HUA</state>
        <zip>970</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Yilan</city>
        <state>ILA</state>
        <zip>26058</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Kaohsiung</city>
        <state>KHH</state>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Kaohsiung</city>
        <state>KHH</state>
        <zip>813</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Tainan</city>
        <state>TNN</state>
        <zip>704</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Tainan</city>
        <state>TNN</state>
        <zip>710</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Taipei City</city>
        <state>TPE</state>
        <zip>10630</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Taipei City</city>
        <state>TPE</state>
        <zip>116</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Taipei</city>
        <state>TPE</state>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Taipei</city>
        <state>TPE</state>
        <zip>11490</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Taichung</city>
        <state>TXG</state>
        <zip>407</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Anthos Investigative Site</name>
      <address>
        <city>Tiachung</city>
        <state>TXG</state>
        <zip>404</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Czechia</country>
    <country>Hungary</country>
    <country>Korea, Republic of</country>
    <country>Poland</country>
    <country>Taiwan</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>February 11, 2021</study_first_submitted>
  <study_first_submitted_qc>February 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>randomized</keyword>
  <keyword>prospective</keyword>
  <keyword>blinded endpoint evaluation</keyword>
  <keyword>abelacimab</keyword>
  <keyword>MAA868</keyword>
  <keyword>rivaroxaban</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>Factor XI</keyword>
  <keyword>stroke</keyword>
  <keyword>bleeding events</keyword>
  <keyword>anti-coagulant</keyword>
  <keyword>anticoagulation therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rivaroxaban</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

